Next Article in Journal
Cytoprotective Effect of Benzyl N'-(5-Chloro-indol-3-yl-methylidene)-hydrazinecarbodithioate Against Ethanol-Induced Gastric Mucosal Injury in Rats
Next Article in Special Issue
Hologram QSAR Models of 4-[(Diethylamino)methyl]-phenol Inhibitors of Acetyl/Butyrylcholinesterase Enzymes as Potential Anti-Alzheimer Agents
Previous Article in Journal
Extraction of Betulin, Trimyristin, Eugenol and Carnosic Acid Using Water-Organic Solvent Mixtures
Previous Article in Special Issue
Prediction of Acute Mammalian Toxicity Using QSAR Methods: A Case Study of Sulfur Mustard and Its Breakdown Products
Open AccessReview

Insights on Cytochrome P450 Enzymes and Inhibitors Obtained Through QSAR Studies

Department of Chemistry, Xavier University of Louisiana, 1 Drexel Dr., New Orleans, LA 70125, USA
Ogden College of Science & Engineering, Western Kentucky University, 1906 College Heights Blvd., Bowling Green, KY 42101, USA
Author to whom correspondence should be addressed.
Molecules 2012, 17(8), 9283-9305;
Received: 29 June 2012 / Revised: 24 July 2012 / Accepted: 26 July 2012 / Published: 3 August 2012
(This article belongs to the Special Issue QSAR and Its Applications)
The cytochrome P450 (CYP) superfamily of heme enzymes play an important role in the metabolism of a large number of endogenous and exogenous compounds, including most of the drugs currently on the market. Inhibitors of CYP enzymes have important roles in the treatment of several disease conditions such as numerous cancers and fungal infections in addition to their critical role in drug-drug interactions. Structure activity relationships (SAR), and three-dimensional quantitative structure activity relationships (3D-QSAR) represent important tools in understanding the interactions of the inhibitors with the active sites of the CYP enzymes. A comprehensive account of the QSAR studies on the major human CYPs 1A1, 1A2, 1B1, 2A6, 2B6, 2C9, 2C19, 2D6, 2E1, 3A4 and a few other CYPs are detailed in this review which will provide us with an insight into the individual/common characteristics of the active sites of these enzymes and the enzyme-inhibitor interactions. View Full-Text
Keywords: 3D-QSAR; SAR; binding/active site; CoMFA; pharmacophore 3D-QSAR; SAR; binding/active site; CoMFA; pharmacophore
Show Figures

Figure 1

MDPI and ACS Style

Sridhar, J.; Liu, J.; Foroozesh, M.; Stevens, C.L.K. Insights on Cytochrome P450 Enzymes and Inhibitors Obtained Through QSAR Studies. Molecules 2012, 17, 9283-9305.

AMA Style

Sridhar J, Liu J, Foroozesh M, Stevens CLK. Insights on Cytochrome P450 Enzymes and Inhibitors Obtained Through QSAR Studies. Molecules. 2012; 17(8):9283-9305.

Chicago/Turabian Style

Sridhar, Jayalakshmi; Liu, Jiawang; Foroozesh, Maryam; Stevens, Cheryl L. Klein. 2012. "Insights on Cytochrome P450 Enzymes and Inhibitors Obtained Through QSAR Studies" Molecules 17, no. 8: 9283-9305.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop